Semaglutide Curbs MASLD Severity in People Living With HIVMarch 13, 2024HepatologyLipid DisordersDiabetesObesityHIVLiver Disease
Does Bariatric Surgery Increase or Decrease Cancer Risk? It Depends.February 26, 2024ObesityColorectal CancerOncologyBariatric SurgeryColon and RectalGastrointestinal CancerGI Oncology
Ozempic is Appealing, but Not Cost-Effective, for Obesity TreatmentJanuary 12, 2024ObesityGastroenterologyEndocrinology
GLP-1 RAs Associated With Reduced Colorectal Cancer Risk in Patients With Type 2 DiabetesDecember 19, 2023DiabetesGastrointestinal CancerOncologyGastroenterologyGI OncologyObesity
Experts offer guidance on GLP-1 receptor agonists prior to endoscopyNovember 7, 2023EndoscopyObesityGastroenterology
FDA gives semaglutide two drug safety–related label changesSeptember 28, 2023DiabetesGastroenterologyObesity
Gastroenterology Data Trends 2023September 26, 2023Mixed TopicsCOVID-19 UpdatesEndoscopyGI OncologyIBD & Intestinal DisordersLiver DiseaseObesity
Half of teens drop below obesity cutoff with semaglutideMay 18, 2023ObesityPediatricsAdolescent Medicine